Latest journalAll journals
EMJ Respiratory 10 [Supplement 2] 2022
The continued inclusion of oral corticosteroids (OCS) in treatment guidelines, as well as the accessibility, familiarity, and relatively low cost of this therapeutic option compared with newer alternatives, has contributed to an ongoing overreliance on OCS treatments in severe asthma. This overuse continues despite accumulating evidence to demonstrate the detrimental long-term effects associated with even a short-term, low-dose course of OCS in this patient population.
Latest articlesAll articles
Congress reviewsAll congress reviews
Review of the European Respiratory Society (ERS) International Congress 2022
PRESENTED in a hybrid format for the first time, this year’s European Respiratory Society (ERS) International Congress welcomed over 19,000 respiratory professionals, with over 10,000 attending in-person in Barcelona, Spain. Known for its stunning buildings, Barcelona is home to many unusual architectural wonders, including Antoni Gaudí’s Casa Batlló, which was classified as a UNESCO World Heritage Site in 2005.
The Impact of Crisis on Healthcare
IN THIS pertinent session, which took place on the second day of the European Respiratory Society (ERS) International Congress 2022, in Barcelona, Spain, experts discussed the impact of crisis on both healthcare providers and patients. Chaired by Anita Simonds, Emeritus Professor of Respiratory and Sleep Medicine, Imperial College London, UK, and Arzu Yorgancıoğlu, Professor and Head of the Department of Pulmonology at Celal Bayar University, Turkey, the session saw experts and patient representatives share their experiences following the crisis of the Ukraine war.